Drug Development Global Program


PATH’s Drug Development program is committed to ensuring that safe and effective medicines are available and accessible to all those who need them.

Guided by a passion for health equity, we work with public- and private-sector stakeholders to develop and advance medicines that prevent and treat diseases disproportionately affecting women and children in low-resource settings. Our areas of focus include enteric and diarrheal diseases, neglected tropical diseases, HIV/AIDS, and malaria.

Like all of PATH’s work, our efforts are rooted in a deep commitment to ensure that health is in reach for everyone and our bold belief in the power of innovation to save lives. Find out more »

If childhood stunting is a three-legged stool, poor gut health is one leg

We spoke to Dr. Mark Manary, a leading expert in childhood malnutrition, to better understand the role of environmental enteric dysfunction in stunting and potential solutions. Learn more »


in the news: Drug trial eyed for one of the leading causes of child mortality »

press release: DRC government steps up commitment to eliminating sleeping sickness by 2020 »

on our blog: Access to safe oxygen will help countries breathe easier »

fact sheet: Diarrhea Innovations Group »

Our work

Stopping diarrhea deaths

Confronting neglected tropical diseases

Addressing HIV/AIDS


Sign up for our e-newsletter

DD-home-enewsSubscribe to our e-newsletter, A Healthy Dose, for a quarterly update on our work. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development. Subscribe now »

Photos from top (clockwise from left): PATH/Rocky Prajapati, PATH/Georgina Goodwin, PATH/Matthew Dakin, and PATH/Gabe Bienczycki.